ANDREA CIGLIOLA: Open Payments
NPI 1851819460 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 97 payments from 16 companies in 2025. Trend: 2023 $591 · 2024 $1,225 · 2025 $1,882
Food & beverage: $1,782Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $603 |
| ABBVIE INC. | 26 | $287 |
| UCB, Inc. | 12 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $142 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Galderma Laboratories, L.P. | 4 | $80 |
| GENZYME CORPORATION | 2 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Organon LLC | 4 | $63 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ILUMYA, DUPIXENT, COSENTYX, RINVOQ, NEMLUVIO.
Industry payments across WA — which companies pay providers there.
